Tag Archives: Genetic Profiling

One More Genetic Link in the Longevity Enigma? (BBC News / Sanger Institute / Nature Communications)

Posted on May 29, 2017 by Dementia and Elderly Care News

Summary People living in the isolated Greek villages of Zoniana and Anogia have a noted tendency to live well into old age. They have a lower than expected incidence of cardiovascular disease, including heart problems, heart attacks and stroke. It … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Stroke, Universal Interest | Tagged 100000 Genomes Project, 100000 Genomes Project Haplotypes, Anogia, Anogia Medical Centre (Greece), APOE, APOE Gene, Array Genotyping, BBC Health News, BMI: Body Mass Index, Body Fat, Body Mass Index (BMI), Cardiometabolic Associations, Cardiovascular Disease (CVD), Cardiovascular Fitness, Cardiovascular Risk, Cardiovascular System Disorders, CDKN2A/B, Cholesterol (HDL), CHRNA3/5, Churchill Hospital (Oxford), Cigarettes, Cretan-Isolated Populations, CVD: Cardiovascular Disease, Department of Nutrition and Dietetics: Harokopio University (Athens), Echinos Medical Centre (Xanthi: Greece), Educational Attainment, Epidemiology, Extra Year in Education Extends Lifespan by 11 months (DNA Study Assertion), FOXO3A, Genetic Correlations: Lifespan and Mortality, Genetic Profiling, Genetic Research, Genetic Variant rs145556679, Genetic Variants, Genetics, Genetics Versus Environment as Determinants of Longevity, Genetics Versus Lifestyle as Determinants of Longevity, Genome-Wide Association Meta-Analysis (GWAMA), Genome-Wide Association Studies, Genome-Wide Association Studies (GWAS), Greece, Greek Villagers, Harokopio University (Athens), HDL-Cholesterol, Heart Disease, HELIC (Hellenic Isolated Cohorts), HELIC MANOLIS Sequencing, High Density Lipoproteins (HDL), High-Density Lipoprotein (HDL) Cholesterol Levels, HLA-DQA1/DRB1, Human Longevity, Insulin Resistance, Isolated Greek Villages, Isolated Populations, Isolated Populations Research, Lifespan, Longevity, Low Density Lipoprotein Cholesterol (LDL-C), Low Density Lipoproteins (LDL), LPA, Lung Cancer, Medical School: University of Exeter, Mendelian Randomisation, METACARPA, Microarrays, Molecular Pathological Epidemiology, Mylopotamos (MANOLIS) and Pomak Villages Cohorts, Mylopotamos: Northern Crete, Nature Communications, Northern Crete, Obesity, Openness to New Experiences, Oxford Centre for Diabetes Endocrinology and Metabolism University of Oxford, Pomak Region of Northern Greece, Population Isolates, Radcliffe Department of Medicine: University of Oxford, Sanger Institute, Saturated Fats, School of Health Science and Education: Harokopio University (Athens), SH2B3, Smoking, Susceptibility to Coronary Artery Disease (CAD), Triglycerides, UK Biobank, Unexpected Genetic Heroes, University of Exeter, University of Exeter Medical School, University of Oxford, Usher Institute of Population Health Sciences and Informatics: University of Edinburgh, Very Low Density Lipoprotein cholesterol (VLDL), Wellbeing and Longevity, Wellcome Trust Centre for Human Genetics: University of Oxford, Wellcome Trust Sanger Institute, Wellcome Trust Sanger Institute: Human Genetics, WGS Haplotypes, Whole Genome Sequencing (WGS), Whole Genome Sequencing and Imputation, Zoniana | Leave a comment

Eleven Genomics Medicine Centres Planned for England (BBC News / Department of Health / NHS England)

Posted on December 22, 2014 by Dementia and Elderly Care News

Summary The NHS has announced further steps in a genetics project, which will involve 11 Genomics Medicine Centres being created in English hospitals to gather DNA information. The aim is to support the 100,000 Genomes Project in research towards the … Continue reading →

UK Genomes Project: Genomics England (BBC News / NHS England / HEE / Nature Genetics)

Posted on August 1, 2014 by Dementia and Elderly Care News

Summary A revolution in medicine is in progress at research centres across the UK, based on unlocking the genetic bases of cancer and other diseases. The UK could become a world leader in genetic research, targeted therapies and personalised medicine. … Continue reading →

Alzheimer’s Disease Genetics Research: Two New Susceptibility Genes (PloS One)

Posted on July 10, 2014 by Dementia and Elderly Care News

Summary An international collaboration of geneticists investigating susceptibility genes for Alzheimer’s Disease has identified two additional genes (chromosome 8 TP53INP1 and chromosome 14 IGHV1-67). These two genetic susceptibility loci appear to be involved in energy metabolism, protein degradation and the … Continue reading →

Posted in BBC News, For Doctors (mostly), For Researchers (mostly), In the News, International, Mental Health, NHS Digital (Previously NHS Choices), Quick Insights, UK | Tagged Alzheimer's Disease Susceptibility Genes, BBC Health News, Behind the Headlines, Boston University School of Medicine, Boston University School of Public Health, Brigham Young University, Cardiff University, Case Western Reserve University, Centre de Mémoire de Ressources et de Recherche de Bordeaux, Centre for Neuropsychiatric Genetics & Genomics: Cardiff University, Centre Hospitalier Régional Universitaire de Lille, Chromosome 14 IGHV1-67, Chromosome 8 TP53INP1, Collaborative Projects, Collaborative Working, Energy Metabolism, Erasmus MC University Medical Center, Functional Genomics Center Zurich, Gene-Wide Analytical Approaches, Genes Linked to Schizophrenia, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genetics of Schizophrenia, Genome-Wide Association Dataset, Genome-Wide Association Studies (GWAS), Hospital Universitari Vall d'Hebron - Institut de Recerca, Immune System, Innovation in Genetics, INSERM, Institut Pasteur de Lille, International Genomics of Alzheimer's Project Consortium, Karolinska Institutet, McGill University and Génome Québec Innovation Centre, Medical University Graz, MRC Centre for Neuropsychiatric Genetics & Genomics, Nature, Nature Publishing Group, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Novel Susceptibility Loci (Alzheimer's Disease), Protein Degradation, Research and Innovation, Research Consortia, Schizophrenia, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Single Nucleotide Polymorphisms (SNPs), Université Lille 2, University of Bonn, University of Miami, University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, University of Texas Health Sciences Center at Houston, University of Washington, University of Zurich, US National Institute of Mental Health, Vanderbilt Center for Human Genetics Research, Vanderbilt University, Victor Segalen University | Leave a comment

Alzheimer’s Disease: Genetics Research Breakthrough (BBC News / NHS Choices / Nature Genetics)

Posted on October 28, 2013 by Dementia and Elderly Care News

Summary An international collaboration of geneticists from 145 academic institutions investigating Alzheimer’s Disease have performed a meta-analysis of data about the DNA of 17,000 patients and 37,000 healthy people. Their analysis of genome-wide association studies (GWAS) has identified 21 genetic … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Alzheimer's Gene (APOE4 Gene), Alzheimer's Research UK, APOE, APOE Gene, Apolipoprotein E (APOE) Gene, BBC Health News, Behind the Headlines, Boston University School of Medicine, Boston University School of Public Health, Broca Hospital, Cardiff University, Centre d'Etude du Polymorphisme Humain (CEPH), Centre for Neuropsychiatric Genetics & Genomics: Cardiff University, Centre National de Génotypage, Cholesterol, Collaborative Projects, Collaborative Working, Columbia University, Commissariat à l'Energie Atomique, Critical Appraisals, DNA, Eidgenössische Technische Hochschule, Endocytosis, Erasmus MC University Medical Center: Rotterdam, Fondation Jean Dausset, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genome-Wide Association Studies (GWAS), Gertrude H. Sergievsky Center: Columbia University, Immune System, Innovation in Genetics, INSERM, Institut Génomique, Institut Pasteur de Lille, International Collaborations, Late-Onset Alzheimer's Disease (LOAD), Medical Research Council (MRC), Medical University of Graz, Memory Clinic of Fundació Alzheimer Centre Educacional (ACE). Institut Català de Neurociències Aplicades, Nature Genetics, Netherlands Consortium for Healthy Aging, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Perelman School of Medicine: University of Pennsylvania, Research and Innovation, Research Consortia, Single Nucleotide Polymorphisms (SNPs), Systematic Reviews and Meta-Analyses, Taub Institute on Alzheimer's Disease and the Aging Brain, Université Lille 2, University College London Institute of Neurology, University of Bonn, University of Iceland, University of Miami, University of Pennsylvania, University of Washington, University Paris Descartes, Wellcome Trust | Leave a comment

Quick Insight: United States Perspective on Dementia Research Funding and Progress (Cure Alzheimer’s Fund)

Posted on August 25, 2013 by Dementia and Elderly Care News

Summary This video gives an overview of the organisations and funding arrangements behind recent collaborative research work on Alzheimer’s Disease, and other form of dementia, in the USA. “Cure Alzheimer’s Fund and the National Institute of Mental Health (NIMH) are … Continue reading →

Posted in Charitable Bodies, For Researchers (mostly), International, Non-Pharmacological Treatments, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Universal Interest | Tagged Alzheimer's Research, Amyloid Proteins, ApoE and Genetics of Alzheimer's Disease, Big Pharma, Collaboration, Collaborative Innovation Networks, Collaborative Projects, Collaborative Working, Cure Alzheimer's Fund, Cure Alzheimer’s Fund Research Consortium, Dementia Research, FDA, Gene CD33, Genetic Profiling, Genetic Research, Genetic Testing, Genetic Triggers, Genetics of Alzheimer's Disease, Genome Biology, Genome Sequencing, Information Sharing, Innovation in Genetics, Medicare and Medicaid, National Institute of Mental Health (NIMH), Partnership and Collaboration, Pharmaceutical Industry, Philanthropy, Pre-Competitive Collaboration, Protein Plaques, Public-Private Partnerships, Research and Development, Research and Innovation, Research Consortia, Research Funding, Research Networks, Research Spending, Translational Research, USA, Variant Call Format (VCF), Venture Capital (Approach to Research), Venture Funding, Whole Genome Sequencing | Leave a comment

Frontotemporal Dementia (BMJ)

Posted on August 13, 2013 by Dementia and Elderly Care News

Summary Frontotemporal dementia involves a diverse range of conditions which are a cause of young onset dementia. There is selective brain atrophy in the frontal and temporal lobes, which requires brain magnetic resonance imaging for accurate diagnosis. Approximately one-quarter of … Continue reading →

Posted in Acute Hospitals, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Mental Health, Quick Insights, Universal Interest | Tagged Arnold Pick, Association for Frontotemporal Degeneration, Behavioural Variant Frontotemporal Dementia (bvFTD), BMJ, Brain Imaging, C9ORF72 Gene, Corticobasal Syndrome (CBS), Dementia Research Centre: UCL Institute of Neurology, Dementia Research Centre: University College London, Frontotemporal Dementia, Frontotemporal Dementia (FTD), Frontotemporal Dementia Support Group, Frontotemporal Dementia With Motor Neurone Disease (FTD-MND), Frontotemporal Lobar Degeneration, Frontotemporal Lobar Dementia (FTD), FUS Protein, Fused in Sarcoma (FUS) Protein, Genetic Profiling, Logopenic Aphasia, Magnetic Resonance Imaging (MRI), Microtubule Associated Protein Tau (MAPT), MRI, MRI Scans, Neurodegeneration, Neurodegenerative Diseases, Neuroimaging, Neurological Disease, Neurology, Pick’s Disease, Progressive Non-Fluent Aphasia (PNFA), Progressive Nonfluent Aphasia, Semantic Dementia, TDP-43, TDP-43 Pathology, Trazodone, UCL Institute of Neurology: University College London, University College London, Valosin Containing Protein (VCP), Young Onset Dementia (YOD) | Leave a comment

Tag Archives: Genetic Profiling

One More Genetic Link in the Longevity Enigma? (BBC News / Sanger Institute / Nature Communications)

Eleven Genomics Medicine Centres Planned for England (BBC News / Department of Health / NHS England)

UK Genomes Project: Genomics England (BBC News / NHS England / HEE / Nature Genetics)

Alzheimer’s Disease Genetics Research: Two New Susceptibility Genes (PloS One)

Alzheimer’s Disease: Genetics Research Breakthrough (BBC News / NHS Choices / Nature Genetics)

Frontotemporal Dementia (BMJ)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites